Wellnex Life Ltd (ASX: WNX) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Wellnex Life Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Wellnex Life Ltd (ASX: WNX)
Latest News
Mergers & Acquisitions
How to ride the ASX infant formula boom in 2020
Share Gainers
Why Appen, Brickworks, Soul Pattinson, & Wattle Health stormed higher today
Share Gainers
Why Alcidion, Helloworld, Nearmap, & Wattle Health shares surged higher today
Share Market News
Is the Bellamy's takeover a signal to invest in infant formula?
52-Week Lows
The Wattle Health share price is down 60% in 2019 and at a two-year low
Share Gainers
Wattle Health share price on watch after acquisition update
Share Market News
Wattle Health share price could fall on quarterly cash outflows, low sales
Share Market News
A2 Milk share price hits new 52-week high – can it surge higher in 2019?
Growth Shares
Has the A2 Milk share price growth capped out in 2019?
Share Fallers
Why CIMIC, Superloop, Syrah, & Wattle Health shares tumbled lower today
Share Market News
Why the Wattle Health share price could fall today
Share Gainers
Why Australian Ethical, Bapcor, Western Areas, & Wattle Health shares stormed higher
WNX ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About Wellnex Life Ltd
Wellnex Life Ltd is a health and wellness company which is engaged in developing health and wellness products. It offers products including nutritional food products, natural baby skincare range, and nutritional health supplement range. The company offers its products through brands such as The Iron Company, Mr Bright, Nighty Night and others.
WNX Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
21 Nov 2024 | $0.63 | $-0.07 | -10.14% | 3,090 | $0.68 | $0.68 | $0.63 |
20 Nov 2024 | $0.69 | $0.03 | 4.58% | 33,024 | $0.65 | $0.69 | $0.62 |
19 Nov 2024 | $0.66 | $0.05 | 8.26% | 44,110 | $0.65 | $0.70 | $0.64 |
18 Nov 2024 | $0.61 | $-0.01 | -1.64% | 6,635 | $0.61 | $0.62 | $0.60 |
15 Nov 2024 | $0.61 | $0.01 | 1.67% | 990 | $0.65 | $0.65 | $0.61 |
14 Nov 2024 | $0.60 | $-0.05 | -7.75% | 22,025 | $0.64 | $0.65 | $0.60 |
13 Nov 2024 | $0.65 | $0.02 | 3.17% | 4,687 | $0.64 | $0.65 | $0.64 |
12 Nov 2024 | $0.63 | $-0.07 | -10.00% | 94,092 | $0.71 | $0.71 | $0.60 |
11 Nov 2024 | $0.70 | $0.01 | 1.44% | 13,646 | $0.71 | $0.71 | $0.69 |
08 Nov 2024 | $0.70 | $0.09 | 14.75% | 6,980 | $0.63 | $0.70 | $0.63 |
07 Nov 2024 | $0.61 | $-0.04 | -6.15% | 79,716 | $0.66 | $0.66 | $0.61 |
06 Nov 2024 | $0.65 | $-0.02 | -2.99% | 23,470 | $0.68 | $0.68 | $0.65 |
05 Nov 2024 | $0.67 | $0.02 | 3.08% | 21,996 | $0.67 | $0.69 | $0.67 |
04 Nov 2024 | $0.65 | $-0.01 | -1.52% | 28,527 | $0.67 | $0.73 | $0.65 |
01 Nov 2024 | $0.66 | $-0.07 | -9.59% | 44,062 | $0.74 | $0.74 | $0.65 |
31 Oct 2024 | $0.73 | $-0.04 | -5.19% | 41,029 | $0.77 | $0.77 | $0.69 |
30 Oct 2024 | $0.77 | $0.00 | 0.00% | 6,915 | $0.79 | $0.79 | $0.77 |
29 Oct 2024 | $0.77 | $-0.21 | -21.54% | 94,647 | $0.95 | $0.95 | $0.77 |
28 Oct 2024 | $0.98 | $0.05 | 5.41% | 41,052 | $1.00 | $1.00 | $0.96 |
25 Oct 2024 | $0.93 | $0.20 | 27.40% | 45,969 | $0.76 | $0.93 | $0.76 |
24 Oct 2024 | $0.73 | $0.11 | 17.74% | 45,476 | $0.62 | $0.77 | $0.62 |
23 Oct 2024 | $0.62 | $0.00 | 0.00% | 17,454 | $0.62 | $0.63 | $0.62 |
22 Oct 2024 | $0.62 | $-0.03 | -4.62% | 35,911 | $0.69 | $0.69 | $0.62 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
17 Oct 2024 | George Karafotias | Buy | 5,000 | $4,420 |
On-market trade. .
|
16 Sep 2024 | Zlatko (Zack) Bozinovski | Buy | 1,190,593 | $25,002 |
On-market trade.
|
14 Dec 2023 | Zheng (Kobe) Li | Issued | 75,000 | $2,100 |
Rights issue.
|
14 Dec 2023 | Zheng (Kobe) Li | Issued | 25,000 | $1,325 |
Rights issue.
|
14 Dec 2023 | Zlatko (Zack) Bozinovski | Issued | 1,250,000 | $35,000 |
Rights issue.
|
14 Dec 2023 | Zlatko (Zack) Bozinovski | Issued | 10,392,857 | $290,999 |
Rights issue.
|
14 Dec 2023 | Zlatko (Zack) Bozinovski | Issued | 3,880,953 | $205,690 |
Rights issue.
|
14 Dec 2023 | Eric Jiang | Issued | 59,524 | $3,154 |
Rights issue.
|
14 Dec 2023 | Eric Jiang | Issued | 178,572 | $5,000 |
Rights issue.
|
14 Dec 2023 | George Karafotias | Issued | 761,905 | $40,380 |
Rights issue.
|
14 Dec 2023 | George Karafotias | Issued | 2,285,713 | $64,000 |
Rights issue.
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr Eric Jiang | Non-Executive Director | Sep 2016 |
Mr Jiang has over 15 years' experience and is an adviser to companies involved in trade between Australia and China. Eric brings understanding of the cultural, economic and strategic context in which Australian businesses engage with China.
|
Mr George Karafotias | Chief Financial OfficerExecutive Director | Nov 2020 |
Mr Karafotias has held roles in public companies over the last 9 years and has previously provided corporate advisory services to listed and unlisted companies, focusing on restructuring and refinancing.
|
Mr George Tambassis | Non-Executive Director | Sep 2024 |
--
|
Mr Zlatko (Zack) Bozinovski | Chief Strategy OfficerExecutive Director | Jul 2021 |
Mr Bozinovski is executive in the Australian retail industry with over 35 years' experience within FMCG and Pharmaceuticals companies in Australia and internationally. Mr Bozinovski co-founded Voost and has previously held senior positions at Uncle Tobys/Goodman Fielder, Pepsi Co and Sigma Pharmaceuticals.
|
Mr Andrew Vidler | Non-Executive Director | Jan 2024 |
Mr Vidler has experience across retail, consumer health products and retail pharmacy. Andrew in his over 30 years' experience includes nearly 20 years with the EBOS Group (formerly FH Faulding, Mayne Group and Symbion), where across roles he led the Terry White and Chemmart pharmacy brands and the Endeavour consumer health products business.
|
Mr Jeffrey Yeh | Non-Executive Director | Jan 2024 |
Mr Yeh is an experienced all-rounded entrepreneur, with over 21 years' experience in all aspects of pharmaceutical sales, marketing, production, quality assurance, operations, logistics, finance and management.
|
Mr Zheng (Kobe) Li | Company Secretary | Jan 2019 |
-
|
Zheng (Kobe) Li | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
Homart Group Pty Ltd | 83,508,573 | 5.96% |
Kobella Holdings Pty Ltd (The Kobella Holding Unit A/C) | 68,571,428 | 4.89% |
Jysf Management Pty Ltd (Jysf A/C) | 65,729,522 | 4.69% |
Kirby Superannuation Pty Ltd (Kirby Super Fund A/C) | 40,154,760 | 2.86% |
Ggp Investments Pty Ltd (Ggp Superannuation Fund A/C) | 32,732,760 | 2.33% |
Citicorp Nominees Pty Limited | 32,661,975 | 2.33% |
Gleneagle Securities Nominees Pty Limited | 32,142,855 | 2.29% |
HSBC Custody Nominees (Australia) Limited | 30,559,496 | 2.18% |
Morrison Securities Pty Ltd (Placements A/C) | 28,836,995 | 2.06% |
Zjl Pty Ltd (The Bozinovski Family A/C) | 24,142,857 | 1.72% |
18120 Pty Ltd (Hmej A/C) | 22,657,143 | 1.62% |
Lotus Capital Group Pty Ltd | 19,882,100 | 1.42% |
Gleneagle Securities (Aust) Pty Ltd | 19,700,000 | 1.41% |
Pear Management Pty Ltd | 19,603,863 | 1.40% |
Reid Jon Zulpo (Rj & Mc Zulpo Family A/C) | 19,021,740 | 1.36% |
Cw Retail Holdings Pty Ltd (Cw Retail Holdings A/C) | 18,869,792 | 1.35% |
Wattle Trading Pty Ltd | 18,831,453 | 1.34% |
Onslow Management Services Pty Ltd Ltd (Esperance A/C) | 17,857,143 | 1.27% |
Monex Boom Securities (Hk) Ltd (Clients Account) | 17,750,302 | 1.27% |
Mrs Jieni Jeffrey | 16,669,265 | 1.19% |